Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PMVP | US
0
0%
Healthcare
Biotechnology
30/06/2024
17/10/2024
1.60
1.61
1.62
1.57
PMV Pharmaceuticals Inc. a precision oncology company engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586 a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing Wild-type p53 or other p53 mutations including R273H R273C R175H G245S R248Q and R282W as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals Inc. and changed its name to PMV Pharmaceuticals Inc. in July 2013. PMV Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Cranbury New Jersey.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
42.8%1 month
29.9%3 months
38.2%6 months
45.5%-
-
0.36
0.06
0.05
1.24
-
-
-74.84M
83.54M
83.54M
-
-
-
-
-22.62
5.82
2.38
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.18
Range1M
0.18
Range3M
0.35
Rel. volume
0.76
Price X volume
259.31K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
InflaRx N.V | IFRX | Biotechnology | 1.55 | 91.27M | 2.65% | n/a | 0.00% |
Tiziana Life Sciences PLC | TLSA | Biotechnology | 0.896 | 90.96M | 1.82% | n/a | 0.00% |
CytomX Therapeutics Inc | CTMX | Biotechnology | 1.16 | 90.62M | -1.69% | 7.67 | -37.61% |
Werewolf Therapeutics Inc. Common Stock | HOWL | Biotechnology | 2.05 | 89.59M | -0.49% | n/a | 35.26% |
BioAtla Inc. | BCAB | Biotechnology | 1.85 | 89.42M | -5.61% | n/a | 5.30% |
Leap Therapeutics Inc | LPTX | Biotechnology | 2.33 | 89.16M | -2.92% | n/a | 0.73% |
MediciNova Inc | MNOV | Biotechnology | 1.805 | 88.53M | -2.43% | n/a | 0.86% |
Clearside Biomedical Inc | CLSD | Biotechnology | 1.15 | 85.96M | 2.68% | n/a | -168.27% |
CASI Pharmaceuticals Inc | CASI | Biotechnology | 5.43 | 83.95M | 0.56% | n/a | 167.26% |
Aclaris Therapeutics Inc | ACRS | Biotechnology | 1.17 | 83.47M | 0.86% | n/a | 2.10% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Saga Communications Inc | SGA | Broadcasting - Radio | 14.35 | 89.85M | 0.07% | 14.47 | 7.10% |
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.6 | 19.19M | 0.80% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 0.98 | 17.70M | -3.92% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 1.24 | 0.53 | Expensive |
Ent. to Revenue | - | 4,005.99 | - |
PE Ratio | - | 40.42 | - |
Price to Book | 0.36 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 38.22 | 72.92 | Lower Risk |
Debt to Equity | 0.06 | -1.24 | Expensive |
Debt to Assets | 0.05 | 0.25 | Cheaper |
Market Cap | 83.54M | 3.78B | Emerging |